BioLineRx (BLRX) EBIT (2013 - 2025)
BioLineRx (BLRX) recorded quarterly EBIT of -$3.4 million in Q4 2025, down 53.42% quarter-over-quarter from -$2.2 million in Q3 2025, and up 23.5% on a YoY basis from -$2.7 million in Q4 2024.
BioLineRx (BLRX) EBIT (2013 - 2025) Analysis & Trends
BioLineRx's EBIT history runs 13 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- In Q4 2025, EBIT rose 23.5% year-over-year to -$3.4 million; the TTM figure through Dec 2025 stood at -$10.3 million (up 49.59% YoY), while the FY2025 annual figure was -$10.3 million, up 49.59% from the prior year.
- EBIT was -$3.4 million for Q4 2025 at BioLineRx, down from -$2.2 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$2.2 million in Q3 2025 to a low of -$18.6 million in Q4 2023.
- Historically, EBIT has averaged -$6.7 million across 5 years, with a median of -$6.1 million in 2021.
- The sharpest annual moves came in 2023 and 2024: EBIT sank 121.08% in 2023, then jumped 76.16% in 2024.
- A 5-year view of EBIT shows it stood at -$6.6 million in 2021, then fell by 27.28% to -$8.4 million in 2022, then tumbled by 121.08% to -$18.6 million in 2023, then surged by 76.16% to -$4.4 million in 2024, then gained by 23.5% to -$3.4 million in 2025.
- The last three EBIT figures came in at -$3.4 million (Q4 2025), -$2.2 million (Q3 2025), and -$2.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.86 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -6.08 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -6.22 Mn |
| Jun 30, 2021 | -6.51 Mn |
| Mar 31, 2021 | -5.45 Mn |